2019
DOI: 10.1080/10408347.2019.1599709
|View full text |Cite
|
Sign up to set email alerts
|

Linezolid—A Review of Analytical Methods in Pharmaceuticals and Biological Matrices

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(3 citation statements)
references
References 51 publications
0
3
0
Order By: Relevance
“…Although linezolid concentrations in CSF have been widely reported in literature, in patients treated for gram-positive bacterial infections, the methods used for quantification have been less widely reported [ 24 , 25 ]. Many of the methods used ultraviolet–visible (UV–vis) spectrophotometry for detection, which is less sensitive than the method described in this article.…”
Section: Resultsmentioning
confidence: 99%
“…Although linezolid concentrations in CSF have been widely reported in literature, in patients treated for gram-positive bacterial infections, the methods used for quantification have been less widely reported [ 24 , 25 ]. Many of the methods used ultraviolet–visible (UV–vis) spectrophotometry for detection, which is less sensitive than the method described in this article.…”
Section: Resultsmentioning
confidence: 99%
“…Several methods have been conducted to determine AMD alone and with other drugs in its pure form and commercial samples: the redox titrimetric method [15], spectrophotometric methods [16][17][18], spectrofluorimetric methods [17,[19][20][21][22][23][24][25][26][27][28], high-performance liquid chromatography [29][30][31][32], thin layer chromatography [30], electroanalytical methods [31,33], and capillary electrophoretic methods [34,35]. Kokilambigai et al have provided a good review of the different analytical methods for determining AMD [36].…”
Section: Introduction and Prefacementioning
confidence: 99%
“…The first oxazolidinone clinically available was Linezolid (LNZ), discovered in 1996 and approved in 2000 for clinical use by the FDA (U.S. Food and Drug Administration) [ 11 ]. LNZ is widely employed for GPB infections and it is considered an efficient drug for surgical infections [ 11 , 12 ] and in the treatment of drug-resistant pulmonary infections and MDR-TB infections. Among oxazolidinones, only LNZ and Tedizolid are clinically approved for MDR-TB infections.…”
Section: Introductionmentioning
confidence: 99%